Questions discussed in this category
This question is part of a collaboration with RheumMadness and is specifically in reference to: CD40L inhibitor for Sjogren's
And how would you monitor response?
Patient has received treatment with Rituximab and is taking hydroxychloroquine.
No evidence of malignancy on serial CT scans.
If so, what test do you use in clinical practice?
1487517911181961574117954102821655216795163521643515285145491392913651878878367739
Papers discussed in this category
Annals of the rheumatic diseases, 1999-04
Rheumatology (Oxford), 2020 Feb 11
J Am Dent Assoc,
Arthritis Rheumatol, 2016 Oct 26
Ann Rheum Dis, 2019 Oct 31
Rheumatology (Oxford),
Rheumatology (Oxford), 2019 Mar 05
Chest, 2021 Feb
J Am Dent Assoc, 2016 Jan 05
The ocular surface, 2015 Jan 15
Rheumatol Int, 2014 Jun 05
Rheumatol Ther, 2020 Dec 24
Lupus, 2019 Jun 19
Ann Rheum Dis, 2011 Nov 09
Autoimmunity reviews, 2017-09
Nat Rev Nephrol, 2015 Nov 16
Ear Nose Throat J, 2015 Jun
Oral Dis, 2021 Mar 12
Oral Dis, 2016 Dec 06
Annals of the rheumatic diseases, 2011 Sep 16